Print

AVEG 013A

NCT00001037

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID)
gp160 Vaccine (Immuno-AG)
RandD/trials/Lists/ClinicalTrialsList
Protein gp160 env B LAI, MN